RxDoctor Payments Data

Morris Washington, MD

Surgery · Myrtle Beach, SCNPI 1801970207

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (40.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Intuitive Surgical at 42.4% of the total. Reporting peaked in 2019 at $9,272 and has fallen 90.1% since, to $918 in 2025. Among surgery clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,584in general payments, 2019–2025

Across 143 payments — averaging $122.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$7K
  • Ambu Inc.$4K
  • Novo Nordisk$1K
  • Johnson & Johnson$1K
  • Apollo Endosurgery US Inc$935
  • W. L. Gore & Associates, Inc.$747
  • plus $3K from 18 others

What the payments were for

  • Consulting fees$3,11518%
  • Travel & lodging$3,35319%
  • Food & beverage$7,11540%
  • Education$4,00023%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,584 in reported general payments places this provider in the 90th percentile of 553 surgery providers in South Carolina.

See all surgery providers in South Carolina

Medicare billing

Part B allowed, 2024
$59,039
Medicare patients
85
Services billed
195

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide11$11,520
Ondansetron OdtOndansetron22$458
Omeprazole17$246
Prochlorperazine Maleate21$153

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$80$11,52011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 553 surgery providers in South Carolina.

Other surgery in Myrtle Beach

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →